The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: Results of a matched multiinstitutional analysis

Advances in Urology

Volumn , Issue , 2012, Pages

  Schubert, Maria ^a   Joniau, Steven ^b   Gontero, Paolo ^c   Kneitz, Susanne ^d   Scholz, Claus Jürgen ^d   Kneitz, Burkhard ^a   Briganti, Alberto ^e   Karnes, R Jeffrey ^f   Tombal, Bertrand ^g   Walz, Jochen ^h   Hsu, Chao Yu ^b   Marchioro, Giansilvio ⁱ   Bader, Pia ^j   Bangma, Chris ^k   Frohneberg, Detlef ^j   Graefen, Markus ^h   Schröder, Fritz ^k   Van Cangh, Paul ^g   Van Poppel, Hein ^b   Spahn, Martin ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f MAYO CLINIC   (United States)

^g UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^j Department of Neurology   (Germany)

^k ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84858182199     PISSN: 16876369     EISSN: 16876377     Source Type: Journal    
DOI: 10.1155/2012/612707     Document Type: Article

References (23)

1. Carver B. S., Bianco F. J., Scardino P. T., Eastham J. A., Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer Journal of Urology 2006 176 2 564 568 (Pubitemid 43927886)
2. Petrovich Z., Lieskovsky G., Stein J. P., Huberman M., Skinner D. G., Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer BJU International 2002 89 6 604 611 (Pubitemid 34948309)
3. Roehl K. A., Han M., Ramos C. G., Antenor J. A. V., Catalona W. J., Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results Journal of Urology 2004 172 3 910 914 (Pubitemid 39096421)
4. Nguyen C. T., Reuther A. M., Stephenson A. J., Klein E. A., Jones J. S., The specific definition of high risk prostate cancer has minimal impact on biochemical relapse-free survival Journal of Urology 2009 181 1 75 80
5. Yossepowitch O., Eggener S. E., Bianco F. J. Jr., Carver B. S., Serio A., Scardino P. T., Eastham J. A., Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods Journal of Urology 2007 178 2 493 499 (Pubitemid 47030486)
6. Pilepich M. V., Caplan R., Byhardt R. W., Lawton C. A., Gallagher M. J., Mesic J. B., Hanks G. E., Coughlin C. T., Porter A., Shipley W. U., Grignon D., Phase III trial of androgen suppression using goserelin in unfavorable- prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group protocol 8531 Journal of Clinical Oncology 1997 15 3 1013 1021 (Pubitemid 27106285)
7. Roach M. III, Bae K., Speight J., Wolkov H. B., Rubin P., Lee R. J., Lawton C., Valicenti R., Grignon D., Pilepich M. V., Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610 Journal of Clinical Oncology 2008 26 4 585 591 (Pubitemid 351264352)
8. Messing E. M., Manola J., Yao J., Kiernan M., Crawford D., Wilding G., di'SantAgnese P. A., Trump D., Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy The Lancet Oncology 2006 7 6 472 479 (Pubitemid 43779173)
9. Zincke H., Lau W., Bergstralh E., Blute M. L., Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer Journal of Urology 2001 166 6 2208 2215 (Pubitemid 33065259)
10. Spahn M., Weiss C., Bader P., Strbel P., Gerharz E. W., Kneitz B., Frohneberg D., Long-term outcome of patients with high-risk prostate cancer following radical prostatectomy and stage-dependent adjuvant androgen deprivation Urologia Internationalis 2010 84 2 164 173
11. Thompson I. M., Tangen C. M., Paradelo J., Lucia M. S., Miller G., Troyer D., Messing E., Forman J., Chin J., Swanson G., Canby-Hagino E., Crawford E. D., Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow-up of a randomized clinical trial Journal of Urology 2009 181 3 956 962
12. Heidenreich A., Bellmunt J., Bolla M., Joniau S., Mason M., Matveev V., Mottet N., Schmid H. P., Van Der Kwast T., Wiegel T., Zattoni F., EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease European Urology 2011 59 1 61 71
13. Vis A. N., Schrder F. H., van der Kwast T. H., The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer European Urology 2006 50 2 258 265 (Pubitemid 44038060)
14. Dorff T. B., Flaig T. W., Tangen C. M., Hussain M. H. A., Swanson G. P., Wood D. P. Jr., Sakr W. A., Dawson N. A., Haas N. B., Crawford E. D., Vogelzang N. J., Thompson I. M., Glode L. M., Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study Journal of Clinical Oncology 2011 29 15 2040 2045
15. Spahn M., Joniau S., Gontero P., Fieuws S., Marchioro G., Tombal B., Kneitz B., Hsu C. Y., Van Der Eeckt K., Bader P., Frohneberg D., Tizzani A., van Poppel H., Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20ng/ml: a European multi-institutional study of 712 patients European Urology 2010 58 1 1 7
16. Hsu C. Y., Joniau S., Oyen R., Roskams T., van Poppel H., Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience European Urology 2007 51 1 121 129 (Pubitemid 44821509)
17. Bolla M., Collette L., Blank L., Warde P., Dubois J. B., Mirimanoff R. O., Storme G., Bernier J., Kuten A., Sternberg C., Mattelaer J., Torecilla J. L., Pfeffer J. R., Cutajar C. L., Zurlo A., Pierart M., Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial The Lancet 2002 360 9327 103 108 (Pubitemid 34786197)
18. Collette L., van Poppel H., Bolla M., Van Cangh P., Vekemans K., Da Pozzo L., De Reijke T. M., Verbaeys A., Bosset J. F., Piérart M., Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC trial 22911) European Journal of Cancer 2005 41 17 2662 2672 (Pubitemid 41607557)
19. van Poppel H., Tombal B., Cardiovascular risk during hormonal treatment in patients with prostate cancer Cancer Management and Research 2011 3 1 49 55
20. Freedland S. J., Humphreys E. B., Mangold L. A., Eisenberger M., Dorey F. J., Walsh P. C., Partin A. W., Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 2005 294 4 433 439 (Pubitemid 41124175)
21. Antonarakis E. S., Chen Y., Elsamanoudi S. I., Brassell S. A., Da Rocha M. V., Eisenberger M. A., McLeod D. G., Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database BJU International 2011 108 3 378 385
22. Siddiqui S. A., Boorjian S. A., Inman B., Bagniewski S., Bergstralh E. J., Blute M. L., Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study Journal of Urology 2008 179 5 1830 1837
23. Spahn M., Kneitz S., Scholz C. J., Stenger N., Rdiger T., Strbel P., Riedmiller H., Kneitz B., Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence International Journal of Cancer 2010 127 2 394 403